Company Performance Metrics
- Rehan Verjee: Co-Founder and CEOPast Role: EMD Serono, President EMD Serono Inc. & Global Head of the Innovative Medicines Franchises
Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology. The company aims to increase drug development success rates and to contribute to a future in which every patient can receive a speedy, minimally invasive diagnosis and therapy tailored to the biology of their
condition. It provides a genome-wide platform that simultaneously explores the dynamic, feature-rich space of gene promoters, gene enhancers, and the DNA methylome from a single milliliter (1 mL) of plasma. It is actively partnering with drug developers to accelerate the development of precision medicines by identifying the biology associated with response and resistance to treatment and by identifying targets mechanistically linked to disease biology.
